Delivery Order SPE2DB22D2206-SPE2DB24FFN80

Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $5.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,877.62, is for the delivery of Lyrica 300 mg capsules. The contract is a firm fixed-price delivery order, with a period of performance through March 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 300 mg capsules, a prescription medication, with a ceiling value of $1,179.94 and a period of performance through March 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Lyrica 75 mg capsules in 90-count packages, with a firm fixed price of $3,232.14 and a completion date of February 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,359.54, is for the supply of Lyrica 100 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of March 19, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Lyrica 150 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,075.80 and a completion date of September 18, 2024. The contract is not set aside for any specific program. AmerisourceBergen, a major pharmaceutical distributor, will supply the medication to support healthcare needs for military treatment facilities, veterans'...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $6,464.88 and is for the delivery of Lyrica 50 mg capsules. The contract is a firm fixed price agreement with a performance period running through March 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award, valued at $1,821.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 150 mg capsules in 90-count packages. This is a firm fixed-price delivery order contract with a completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lyrica 50 mg capsules. The $1,626.00 contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with the Defense Logistics Agency with a potential value of $999,999,999.00 and a performance period through...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 75 mg capsules. The $12,389.87 order has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of a prescription medication, Lyrica 150 mg capsules. The contract has a ceiling value of $3,817.98 and a performance period ending on September 19, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FFN80
    Delivery Order

This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a major pharmaceutical sourcing and distribution company. The contract is for the delivery of Lyrica 300 mg capsules in quantities of 90s. It is a firm fixed price delivery order with a potential value of $5,682.48 and a completion date of February 12, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/10/24, 9:17 AM